Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3215]

FDA approves bortezomib retreatment in patients with multiple myeloma

FDA approves bortezomib retreatment in patients with multiple myeloma

Weakness of leukaemic stem cells discovered

Weakness of leukaemic stem cells discovered

Study identifies rational drug combinations that may overcome mantle cell lymphoma resistance to ibrutinib

Study identifies rational drug combinations that may overcome mantle cell lymphoma resistance to ibrutinib

Discovery of protein's role in making platelets may aid multiple myeloma patients

Discovery of protein's role in making platelets may aid multiple myeloma patients

FDA approves idelalisib for the treatment of patients with relapsed chronic lymphocytic leukemia

FDA approves idelalisib for the treatment of patients with relapsed chronic lymphocytic leukemia

ASH report: Deep budget cuts have devastating impact on biomedical research in US

ASH report: Deep budget cuts have devastating impact on biomedical research in US

Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe

Differences in treatment likely to be behind differing survival rates for blood cancers between regions within...

New test predicts survival and disease progression in blood cancer patients

New test predicts survival and disease progression in blood cancer patients

$FDA approves belinostat for relapsed or refractory peripheral T-cell lymphoma$

FDA approves belinostat for relapsed or refractory peripheral T-cell lymphoma

HIV-infected people with early-stage cancers are up to four times more likely to go untreated for cancer

HIV-infected people with early-stage cancers are up to four times more likely to go untreated for cancer

More from ecancer